Deep-learning-driven dose prediction and verification for stereotactic radiosurgical treatment of isolated brain metastases
Frontiers in Oncology · 20.11.2023 · 13
DOI: 10.3389/fonc.2023.1285555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.11.2023. Verfasst von Jinghui Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Electronic Information, Wuhan University, Wuhan, Hubei, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
While deep learning has shown promise for automated radiotherapy planning, its application to the specific scenario of stereotactic radiosurgery (SRS) for brain metastases using fixed-field intensity modulated radiation therapy (IMRT) on a linear accelerator remains limited. This work aimed to develop and verify a deep learning-guided automated planning protocol tailored for this scenario.
Methods
We collected 70 SRS plans for solitary brain metastases, of which 36 cases were for training and 34 for testing. Test cases were derived from two distinct clinical institutions. The envisioned automated planning process comprised (1): clinical dose prediction facilitated by deep-learning algorithms (2); transformation of the forecasted dose into executable plans via voxel-centric dose emulation (3); validation of the envisaged plan employing a precise dosimeter in conjunction with a linear accelerator. Dose prediction paradigms were established by engineering and refining two three-dimensional UNet architectures (UNet and AttUNet). Input parameters encompassed computed tomography scans from clinical plans and demarcations of the focal point alongside organs at potential risk (OARs); the ensuing output manifested as a 3D dose matrix tailored for each case under scrutiny.
Results
Dose estimations rendered by both models mirrored the manual plans and adhered to clinical stipulations. As projected by the dual models, the apex and average doses for OARs did not deviate appreciably from those delineated in the manual plan (P-value≥0.05). AttUNet showed promising results compared to the foundational UNet. Predicted doses showcased a pronounced dose gradient, with peak concentrations localized within the target vicinity. The executable plans conformed to clinical dosimetric benchmarks and aligned with their associated verification assessments (100% gamma approval rate at 3 mm/3%).
Conclusion
This study demonstrates an automated planning technique for fixed-field IMRT-based SRS for brain metastases. The envisaged plans met clinical requirements, were reproducible across centers, and achievable in deliveries. This represents progress toward automated paradigms for this specific scenario.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Electronic Information, Wuhan University, Wuhan, Hubei, China.
- Department of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
- Department of Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
- Department of Radiation Oncology, Jiangling County People's Hospital, Jingzhou, Hubei, China.
Zitieren
APA
Pan, J., Xiao, J., Ruan, C., Song, Q., Shi, L., Zhuo, F., Jiang, H., & Li, X. (2023). Deep-learning-driven dose prediction and verification for stereotactic radiosurgical treatment of isolated brain metastases. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1285555
Vancouver
Pan J, Xiao J, Ruan C, Song Q, Shi L, Zhuo F, et al. Deep-learning-driven dose prediction and verification for stereotactic radiosurgical treatment of isolated brain metastases. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1285555
BibTeX
@article{Pan2023,
author = {Pan, Jinghui and Xiao, Jinsheng and Ruan, Changli and Song, Qibin and Shi, Lei and Zhuo, Fengjiao and Jiang, Hao and Li, Xiangpan},
title = {Deep-learning-driven dose prediction and verification for stereotactic radiosurgical treatment of isolated brain metastases},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1285555}
}
EUVIMED